PetLife Pharmaceuticals, Inc. Interest Expense
PetLife Pharmaceuticals, Inc. reported Interest Expense of $2.78 thousand for the 3-month period ending 2014-05-31, per its 10-Q filed 2014-08-05.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2014-08-05
- PetLife Pharmaceuticals, Inc. interest expense for the quarter ending 2014-05-31 was $2.78K, a 82.45% decline year-over-year.
- PetLife Pharmaceuticals, Inc. interest expense for the quarter ending 2014-02-28 was $2.75K, a 96.82% decline year-over-year.
- PetLife Pharmaceuticals, Inc. interest expense for the quarter ending 2013-11-30 was $2.75K, a 22.90% increase year-over-year.
- PetLife Pharmaceuticals, Inc. interest expense for the quarter ending 2013-08-31 was $3.36K.
- PetLife Pharmaceuticals, Inc. interest expense for fiscal 2013 was $108.14K, a 313.97% increase from fiscal 2012.
- PetLife Pharmaceuticals, Inc. interest expense for fiscal 2012 was $26.12K.
| Period end | Interest Expense 3 month | Interest Expense 4 month | Interest Expense 6 month | Interest Expense 8 month | Interest Expense 9 month | Interest Expense 10 month | Interest Expense 12 month | Interest Expense 13 month | Interest Expense 16 month | Interest Expense 19 month | Interest Expense 34 month | Interest Expense 37 month | Interest Expense 40 month | Interest Expense 43 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-05-31 | $2.78K 10-Q · filed 2014-08-05 | $5.54K derived: sum of 2 quarters · filed 2014-08-05 | $8.26K 10-Q · filed 2014-08-05 | $11.65K derived: sum of 4 quarters · filed 2014-08-05 | $147.76K 10-Q · filed 2014-08-05 | |||||||||
| 2014-02-28 | $2.75K 10-Q · filed 2014-08-05 | $5.48K 10-Q · filed 2014-08-05 | $8.86K derived: sum of 3 quarters · filed 2014-08-05 | $24.73K derived: sum of 4 quarters · filed 2014-08-05 | $144.98K 10-Q · filed 2014-08-05 | |||||||||
| 2013-11-30 | $2.75K 10-Q · filed 2014-08-05 | $6.11K derived: sum of 2 quarters · filed 2014-08-05 | $21.97K derived: sum of 3 quarters · filed 2014-08-05 | $108.66K derived: sum of 4 quarters · filed 2014-08-05 | $142.25K 10-Q · filed 2014-08-05 | |||||||||
| 2013-08-31 | $3.36K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-21 | $19.22K derived: sum of 2 quarters · filed 2014-08-05 | $105.90K derived: sum of 3 quarters · filed 2014-08-05 | $108.14K 10-K · filed 2014-07-21 | $139.50K 10-K · filed 2014-07-21 | |||||||||
| 2013-05-31 | $15.86K 10-Q · filed 2014-08-05 | $102.54K derived: sum of 2 quarters · filed 2014-08-05 | $104.78K 10-Q · filed 2014-08-05 | |||||||||||
| 2013-02-28 | $86.68K 10-Q · filed 2014-08-05 | $88.92K 10-Q · filed 2014-08-05 | ||||||||||||
| 2012-11-30 | $2.24K 10-Q · filed 2014-08-05 | |||||||||||||
| 2012-08-31 | $26.12K 10-K · filed 2014-07-21 | |||||||||||||
| 2012-05-31 | $8.95K 10-Q · filed 2012-07-23 | $14.40K derived: sum of 2 quarters · filed 2012-07-23 | $20.10K 10-Q · filed 2012-07-23 | $20.10K derived: sum of 3 quarters · filed 2012-07-23 | $25.34K 10-Q · filed 2012-07-23 | |||||||||
| 2012-02-28 | $5.45K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2012-04-23 | $5.45K 10-Q · filed 2012-04-23 | $11.15K 10-Q · filed 2012-04-23 | $16.39K 10-Q · filed 2012-04-23 | ||||||||||
| 2011-11-30 | $5.70K 10-Q/A · filed 2012-01-25 | $10.94K 10-Q/A · filed 2012-01-25 | ||||||||||||
| 2011-08-31 | $5.24K 10-K/A · filed 2012-04-05 |